The authors investigated both clinical samples and CRC cell lines, demonstrating that TIM-3 is significantly upregulated in CRC tissues compared to adjacent non-cancerous tissues at both the mRNA and protein levels. This evidence concerns the gene HAVCR2 and colorectal carcinoma.